Draft Guidance for Industry Oversight of Clinical Investigations - A Risk Based Approach to Monitoring
This webinar session is scheduled at the customer's convenience. Please call 585-381-1350 x246 to schedule.
This new draft guidance, that was released last summer, replaces the 1988 Monitoring guidance. FDA has updated its monitoring guidance with some of the current monitoring practices, especially those using EDC systems. FDA has retained some existing practices and proposed some “radical” (some say) changes. The guidance proposes that each Sponsor develop a specific monitoring plan for each study based on the study risk and that includes both on-site and “centralized” (or “remote”) monitoring.
Lorraine D. Ellis, MS, MBA.
Ms. Ellis is an experienced trainer with in-depth knowledge as a result of hands-on experience in clinical trials and training thousands of clinical research professionals over decades. Ms. Ellis has over 30 years clinical research experience and is the author of several books, articles and other clinical research materials. She has authored and taught over 50 courses designed for clinical research professionals.
She has presented at major industry meetings such as DIA, ACRP, CRO Partnerships and others. Ellis has also served as faculty for ACRP courses, participated in the development of ACRP certification programs, and is an adjunct professor in the MS in Clinical Research Management program at Rochester Institute of Technology.
$99 per person
If you are interested in attending/scheduling this webinar, Contact us at 585-381-1350 x246.
For other available webinars or on-site courses
Visit our website's training section or Contact us at 585-381-1350 x246.